Researchers tracked data from more than 400,000 patients for a new meta-analysis, presenting their findings in the Journal of the American Heart Association.
Healthcare technology companies can now use AFib findings recorded by an Apple Watch to help demonstrate the effectiveness of their devices to the FDA.
Sunil Rao, MD, director of interventional cardiology at NYU Langone, says DanGer Shock is a "very, very important study" when it comes to the treatment of cardiogenic shock.
A new meta-analysis of 28 different studies confirmed that robotic-assisted radical nephrectomy with IVC thrombectomy is a safe treatment option for kidney cancer.
The new analysis, presented at ESC Congress 2022, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk.
A new study in JACC: Cardiovascular Imaging focuses on a potential new side effect of COVID-19, highlighting the continued importance of monitoring these patients going forward.
William C. Roberts, MD, has long been one of cardiology’s leading voices, contributing to more than 1,600 academic articles and working in a variety of roles for the American College of Cardiology, American Heart Association and National Institutes of Health.
An international team of researchers, led by specialists from Cleveland Clinic, found that DAPT was consistently linked to a greater risk of major or life-threatening bleeding events.
Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."
![When kidney cancer invades a patient’s inferior vena cava (IVC), robotic-assisted radical nephrectomy with IVC thrombectomy is a safe and effective alternative to open surgery, according to a new meta-analysis published in the Journal of Urology.[1]](/sites/default/files/styles/240x220/public/2022-08/screen_shot_2022-08-22_at_11.09.53_am.png.webp?itok=hS7Q-65H)
